NASDAQ:FENC
Fennec Pharmaceuticals Inc.
- Stock
Last Close
8.00
06/11 21:00
Market Cap
163.93M
Beta: 0.16
Volume Today
65.31K
Avg: 80.91K
PE Ratio
−11.72
PFCF: −16.43
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 288K - | 1.36M 372.39% | |||||||||
average payables | 260K - | 302.50K 16.35% | 270.50K 10.58% | 549.50K 103.14% | 943.50K 71.70% | 1.32M 40.12% | 1.59M 20.39% | 1.17M 26.23% | 1.58M 34.88% | 3.08M 94.81% | |
average receivables | 772.50K - | 5.16M 567.57% | |||||||||
book value per share | 0.06 - | 0.05 18.50% | 0.28 452.55% | 1.78 537.23% | 1.12 37.11% | 0.59 46.92% | 1.23 106.14% | 0.61 50.55% | -0.10 116.12% | -0.44 345.02% | |
capex per share | |||||||||||
capex to depreciation | |||||||||||
capex to operating cash flow | |||||||||||
capex to revenue | |||||||||||
cash per share | 0.23 - | 0.09 62.77% | 0.31 253.50% | 1.88 511.99% | 1.20 36.35% | 0.68 42.92% | 1.28 87.20% | 0.81 36.62% | 0.90 11.52% | 0.50 45.10% | |
days of inventory on hand | 2.44K - | 610.66 75.02% | |||||||||
days payables outstanding | 10.14K - | 1.08K 89.39% | |||||||||
days sales outstanding | 367.38 - | 147.89 59.74% | |||||||||
debt to assets | 0.22 - | 0.92 315.33% | 1.11 19.67% | ||||||||
debt to equity | 0.32 - | -9.69 3,164.63% | -2.56 73.62% | ||||||||
dividend yield | |||||||||||
earnings yield | -0.08 - | -0.03 57.42% | -0.10 192.78% | -0.05 54.16% | -0.08 74.02% | -0.10 18.01% | -0.10 5.52% | -0.15 50.32% | -0.10 35.45% | -0.05 44.35% | |
enterprise value | 24.25M - | 17.94M 26.00% | 23.37M 30.26% | 122.18M 422.76% | 98.54M 19.35% | 115.90M 17.62% | 146.25M 26.19% | 98.31M 32.78% | 253.37M 157.71% | 314.52M 24.14% | |
enterprise value over ebitda | -6.78 - | -5.75 15.13% | -7.90 37.26% | -17.92 126.91% | -9.32 48.02% | -8.91 4.38% | -8.13 8.72% | -5.72 29.65% | -11.24 96.46% | -24.18 115.18% | |
ev to operating cash flow | -14.27 - | -9.64 32.48% | -11.00 14.19% | -33.56 204.96% | -12.59 62.48% | -12.79 1.60% | -9.38 26.69% | -6.91 26.29% | -14.03 102.96% | ||
ev to sales | 860.30 - | 165.06 - | 14.53 91.20% | ||||||||
free cash flow per share | -0.17 - | -0.17 0.08% | -0.17 3.25% | -0.24 45.74% | -0.41 69.71% | -0.45 10.28% | -0.66 44.95% | -0.55 16.88% | -0.69 25.67% | ||
free cash flow yield | -0.06 - | -0.10 54.10% | -0.08 21.09% | -0.02 68.89% | -0.06 166.54% | -0.07 8.41% | -0.09 26.27% | -0.12 40.74% | -0.07 42.40% | ||
graham net net | 0.06 - | 0.04 21.64% | 0.28 534.60% | 1.77 542.14% | 1.11 37.28% | 0.57 48.73% | 1.18 107.19% | 0.56 52.93% | -0.16 129.35% | -0.66 302.18% | |
graham number | 0.55 - | 0.26 52.56% | 1.17 345.36% | 4.34 269.96% | 3.62 16.52% | 2.89 20.18% | 4.57 58.02% | 3.03 33.74% | 1.44 52.35% | 2.45 70.13% | |
income quality | 0.78 - | 2.83 261.88% | 0.76 73.05% | 0.52 32.15% | 0.79 53.16% | 0.71 10.39% | 0.86 21.43% | 0.82 4.79% | 0.76 7.12% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -1.44K - | -136.69 - | -23.10 83.10% | -3.47 84.98% | |||||||
interest debt per share | 0.00 - | 0.20 - | 0.98 400.82% | 1.25 27.28% | |||||||
inventory turnover | 0.15 - | 0.60 300.33% | |||||||||
invested capital | 0.32 - | -9.69 3,164.63% | -2.56 73.62% | ||||||||
market cap | 26.55M - | 18.88M 28.88% | 27.30M 44.55% | 150.44M 451.10% | 121.32M 19.36% | 129.55M 6.78% | 176.59M 36.32% | 114.43M 35.20% | 252.24M 120.44% | 298.16M 18.20% | |
net current asset value | 613K - | 548K 10.60% | 3.57M 551.46% | 26.76M 649.50% | 21.31M 20.35% | 11.61M 45.51% | 29.07M 150.32% | 15.74M 45.84% | -2.78M 117.66% | -13.57M 388.24% | |
net debt to ebitda | 0.65 - | 0.30 53.17% | 1.33 339.17% | 4.15 212.44% | 2.15 48.04% | 1.05 51.29% | 1.69 60.80% | 0.94 44.43% | -0.05 105.32% | -1.26 2,420.86% | |
net income per share | -0.22 - | -0.06 72.39% | -0.22 258.96% | -0.47 114.79% | -0.52 10.80% | -0.62 20.04% | -0.76 21.12% | -0.67 11.22% | -0.95 40.84% | -0.61 34.96% | |
operating cash flow per share | -0.17 - | -0.17 0.08% | -0.17 3.25% | -0.24 45.74% | -0.41 69.71% | -0.45 10.28% | -0.66 44.95% | -0.55 16.88% | -0.69 25.67% | ||
payables turnover | 0.04 - | 0.34 842.70% | |||||||||
receivables turnover | 0.99 - | 2.47 148.41% | |||||||||
research and ddevelopement to revenue | 30.03 - | 2.30 - | 0.00 99.89% | ||||||||
return on tangible assets | -0.92 - | -0.65 29.50% | -0.70 8.57% | -0.25 64.67% | -0.43 73.67% | -0.88 104.44% | -0.57 35.24% | -0.78 36.52% | -0.92 18.39% | -0.61 33.70% | |
revenue per share | 0.01 - | 0.06 - | 0.81 1,294.02% | ||||||||
roe | -3.55 - | -1.20 66.12% | -0.78 35.04% | -0.26 66.29% | -0.46 76.18% | -1.05 126.16% | -0.62 41.24% | -1.11 79.52% | 9.67 973.60% | 1.41 85.38% | |
roic | -4.69 - | -3.43 26.78% | -0.80 76.64% | -0.26 67.82% | -0.47 82.60% | -1.07 126.76% | -0.61 43.01% | -0.83 37.12% | -1.06 26.91% | -0.72 31.81% | |
sales general and administrative to revenue | 76.18 - | 11.55 - | |||||||||
shareholders equity per share | 0.06 - | 0.05 18.50% | 0.28 452.55% | 1.78 537.23% | 1.12 37.11% | 0.59 46.92% | 1.23 106.14% | 0.61 50.55% | -0.10 116.12% | -0.44 345.02% | |
stock based compensation to revenue | 16.42 - | 2.66 - | |||||||||
tangible asset value | 613K - | 548K 10.60% | 3.57M 551.46% | 26.76M 649.50% | 21.31M 20.35% | 11.88M 44.28% | 29.07M 144.80% | 15.77M 45.74% | -2.57M 116.29% | -11.56M 350.08% | |
tangible book value per share | 0.06 - | 0.05 18.50% | 0.28 452.55% | 1.78 537.23% | 1.12 37.11% | 0.59 46.92% | 1.23 106.14% | 0.61 50.55% | -0.10 116.12% | -0.44 345.02% | |
working capital | 613K - | 548K 10.60% | 3.57M 551.46% | 26.76M 649.50% | 21.31M 20.35% | 11.61M 45.51% | 29.07M 150.32% | 20.73M 28.68% | 22.12M 6.68% | 17.20M 22.23% |
All numbers in USD (except ratios and percentages)